These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27233303)

  • 1. Aging does not affect soluble guanylate cyclase redox state in mouse aortas.
    Shimosato T; Tawa M; Iwasaki H; Imamura T; Okamura T
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27233303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
    Britt RD; Thompson MA; Kuipers I; Stewart A; Vogel ER; Thu J; Martin RJ; Pabelick CM; Prakash YS
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L537-42. PubMed ID: 26254425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
    Jabs A; Oelze M; Mikhed Y; Stamm P; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Kopp M; Steven S; Schulz E; Stasch JP; Münzel T; Daiber A
    Vascul Pharmacol; 2015 Aug; 71():181-91. PubMed ID: 25869522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS; Keim Y; Stasch JP; Baxter GF
    Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble guanylate cyclase redox state under hypoxia or hypoxia/reoxygenation in isolated monkey coronary arteries.
    Tawa M; Geddawy A; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Pharmacol Sci; 2014; 125(2):169-75. PubMed ID: 24859780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
    Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
    J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
    Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
    Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
    Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
    BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
    PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
    Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
    J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
    Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
    Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.